Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,427 public trials 3,296 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.

NCT03076216

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Cedars Sinai Department of Radiation Oncology Los Angeles, California, United States
  • Moffitt Cancer Centre Tampa, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane

NCT03003078

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Corrimal Cancer Care Clinic, 20-22 Underwood St Corrimal, New South Wales, Australia
  • Department of Medical Oncology, Royal North Shore Hospital St Leonards, New South Wales, Australia
  • The Kinghorn Cancer Centre, St Vincent's Hospital Sydney, New South Wales, Australia
  • The Crown Princess Mary Cancer Centre, Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Completed

NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b)

NCT00598975

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations
  • Investigator Site - Scottsdale Scottsdale, Arizona, United States
  • Investigator Site - Louisville Louisville, Kentucky, United States
  • Investigator Site - Dallas Dallas, Texas, United States
  • Investigator Site - Tyler Tyler, Texas, United States
View Trial Details
Completed

NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer

NCT00856375

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Investigator Site - Peoria Peoria, Arizona, United States
  • Investigator Site - Burbank Burbank, California, United States
  • Investigator Site - Los Angeles Los Angeles, California, United States
  • Investigator Site - Vallejo Vallejo, California, United States
View all 24 locations
View Trial Details

Related conditions